ORITAVANCIN-FORMULIERUNGEN

Patent europeic · EP3416672 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3416672
Numer da la dumonda
EP17753910
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-02-2017
Publitgà
26-12-2018
Concedì
23-10-2024
La protecziun finescha il pli tard
16-02-2037
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61K 38/14 (2006.01)
A61K 47/40 (2006.01)
A61P 31/04 (2006.01)
Prioritad
US 201662296989 P 18.02.2016
Dumonda PCT
PCT/US2017/018340 17.02.2017
Publicaziun PCT
WO2017/143169 24.08.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 03-09-2025

    Midada

    Published in Swissreg on 03.09.2025

  3. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  4. 26-10-2024

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 26.10.2024

  5. 23-10-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.10.2024

Partidas

Possessur

Melinta Therapeutics, LLC

389 Interpace Parkway Suite 450, Parsippany, NJ 07054, US

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

GRIFFITH, David, C.

Parsippany NJ 07054, US

FAR, Adel, Rafai

Parsippany NJ 07054, US

LEHOUX, Dario

Parsippany NJ 07054, US

KRISHNA, Gopal

Parsippany NJ 07054, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.